ALEX ZOPO: Open Payments
NPI 1184658718 · BOYNTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 15 payments from 9 companies in 2025. Trend: 2023 $387 · 2024 $468 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $158 |
| Astellas Pharma US Inc | 3 | $91 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $34 |
| Corcept Therapeutics | 1 | $28 |
| Eisai Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: AIRSUPRA, Veozah, ELIQUIS, Kerendia, MOUNJARO, Korlym, Leqembi, KEVEYIS.
Industry payments across FL — which companies pay providers there.
